Par Pharmaceutical recalls
5 recalls filed under Par Pharmaceutical. The most recent was published October 8, 2026.
-
Highest risk · 25 days ago
Par Pharmaceutical Brevital Sodium 500 mg/vial for Injection recall: Presence of particulate matter identified as cellulose
Presence of particulate matter identified as cellulose
-
Highest risk · last month
Par Pharmaceutical Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 recall: Presence of particulate matter identified as cellulose or stopper material
Presence of particulate matter identified as cellulose or stopper material
-
Elevated risk · 1+ years ago
Par Pharmaceutical Adrenalin® Chloride Solution recall: Product is an unapproved drug
Product is an unapproved drug.
-
Elevated risk · 2+ years ago
Par Pharmaceutical Clonazepam Orally Disintegrating Tablets, USP recall: Mislabeled with the incorrect strength on the carton
Mislabeled with the incorrect strength on the carton
-
Elevated risk · 2+ years ago
Par Pharmaceutical Treprostinil 20mg/20mL Injection recall: Potential Presence of Silicone Particulate Matter
Potential Presence of Silicone Particulate Matter
About this page
Par Pharmaceutical appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.